Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Thermo Fisher Scientific to accelerate genomic profiling process in hematology and oncology labs

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

FDA approves Ohio State-developed drug to treat patients with CLL and SCL

Cancer drug shows promise in treating metabolic syndrome

Cancer drug shows promise in treating metabolic syndrome

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

Rutgers researcher receives $600,000 grant to study chronic lymphocytic leukemia

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

MD Anderson and Takeda announce agreement to develop off-the-shelf CAR NK-cell therapy platform

Scientists harness the power of immune system to test novel cancer treatment

Scientists harness the power of immune system to test novel cancer treatment

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Leukemia is not just one disease

Leukemia is not just one disease

People who have a parent, sibling, or child with blood cancer have higher risk of disease

People who have a parent, sibling, or child with blood cancer have higher risk of disease

New leukemia treatment developed from common wild flower

New leukemia treatment developed from common wild flower

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Combination treatment effective as front-line therapy for select chronic lymphocytic leukemia patients

Study identifies patterns of chronic lymphocytic leukemia growth

Study identifies patterns of chronic lymphocytic leukemia growth

Researchers identify why lymphoma patients may become resistant to specific drug

Researchers identify why lymphoma patients may become resistant to specific drug

New test could be a ‘game changer’ in the treatment of chronic lymphocytic leukemia

New test could be a ‘game changer’ in the treatment of chronic lymphocytic leukemia

EU-funded project investigates molecular mechanisms of aging in adult stem cells

EU-funded project investigates molecular mechanisms of aging in adult stem cells